CN101939651A - 用于检测严重有害的心血管和脑血管事件的方法 - Google Patents

用于检测严重有害的心血管和脑血管事件的方法 Download PDF

Info

Publication number
CN101939651A
CN101939651A CN2008801210762A CN200880121076A CN101939651A CN 101939651 A CN101939651 A CN 101939651A CN 2008801210762 A CN2008801210762 A CN 2008801210762A CN 200880121076 A CN200880121076 A CN 200880121076A CN 101939651 A CN101939651 A CN 101939651A
Authority
CN
China
Prior art keywords
analyte
cardiovascular
concentration
cerebrovascular events
people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801210762A
Other languages
English (en)
Chinese (zh)
Inventor
P·蒙滕丹
R·巴拉苏布拉马尼安
R·迈尔斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BG Medicine Inc
Original Assignee
BG Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BG Medicine Inc filed Critical BG Medicine Inc
Publication of CN101939651A publication Critical patent/CN101939651A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0009—Calibration of the apparatus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
CN2008801210762A 2007-10-10 2008-10-10 用于检测严重有害的心血管和脑血管事件的方法 Pending CN101939651A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99856307P 2007-10-10 2007-10-10
US60/998563 2007-10-10
US99875607P 2007-10-11 2007-10-11
US60/998756 2007-10-11
PCT/US2008/079553 WO2009049189A2 (en) 2007-10-10 2008-10-10 Methods for detecting major adverse cardiovascular and cerebrovascular events

Publications (1)

Publication Number Publication Date
CN101939651A true CN101939651A (zh) 2011-01-05

Family

ID=40289424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801210762A Pending CN101939651A (zh) 2007-10-10 2008-10-10 用于检测严重有害的心血管和脑血管事件的方法

Country Status (10)

Country Link
US (1) US20110045514A1 (enExample)
EP (1) EP2210108B1 (enExample)
JP (1) JP2011501133A (enExample)
CN (1) CN101939651A (enExample)
AT (1) ATE536553T1 (enExample)
AU (1) AU2008310669A1 (enExample)
CA (1) CA2702268A1 (enExample)
ES (1) ES2374762T3 (enExample)
IL (1) IL204922A0 (enExample)
WO (1) WO2009049189A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105866261A (zh) * 2016-03-24 2016-08-17 中国药科大学 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物群
WO2017128161A1 (zh) * 2016-01-25 2017-08-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
WO2017128162A1 (zh) * 2016-01-25 2017-08-03 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN108027354A (zh) * 2015-08-20 2018-05-11 深圳华大生命科学研究院 冠心病的生物标志物

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8620738B2 (en) * 2006-08-31 2013-12-31 Visa U.S.A. Inc Loyalty program incentive determination
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
EP2199956A1 (en) * 2008-12-18 2010-06-23 Siemens Aktiengesellschaft Method and system for managing results of an analysis process on objects handled along a technical process line
JP5728488B2 (ja) 2009-11-13 2015-06-03 ビージー メディシン， インコーポレイテッド 心筋梗塞のリスクファクターおよび予測
ES2728120T3 (es) * 2010-01-29 2019-10-22 Metanomics Gmbh Medios y procedimientos para diagnosticar insuficiencia cardíaca en un sujeto
BR112012018771A2 (pt) * 2010-01-29 2017-06-20 Metanomics Gmbh ''método para dianosticar insuficência cardíaca em um sujeito''
CN106055895B (zh) * 2010-09-15 2021-02-19 Dh科技发展私人贸易有限公司 产物离子谱的数据独立获取及参考谱库匹配
EP2592422A1 (en) * 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
EP3968026A1 (en) 2012-03-26 2022-03-16 XCellCure, LLC Device and method for detection of analytes
AU2014227891A1 (en) * 2013-03-15 2015-10-08 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
KR101660328B1 (ko) 2014-01-14 2016-09-27 한국과학기술연구원 심혈관 질환 진단용 바이오 마커
US9933425B2 (en) 2014-04-10 2018-04-03 MEP Equine Solutions LLC Method for the quantification of parasite eggs in feces
EP3172564A4 (en) * 2014-07-18 2018-06-27 Genova Diagnostics, Inc. Use of an evidence-based, translational algorithm to, inter alia, assess biomarkers
US20180238914A1 (en) * 2015-08-19 2018-08-23 Metanomics Gmbh Means and methods for diagnosing cardiac disease in a subject
CN105223264B (zh) * 2015-09-21 2017-12-29 广东联捷生物科技有限公司 一种质谱定量分析的模拟内标方法、装置及应用
WO2017178453A1 (en) * 2016-04-14 2017-10-19 Roche Diagnostics Gmbh Method for determining a concentration of a target analyte in a sample of bodily fluid
CA3087305A1 (en) * 2017-12-13 2019-06-20 Glx Analytix Aps Biomarkers for multiple sclerosis
JP7280582B2 (ja) * 2018-09-12 2023-05-24 株式会社島津製作所 心房細動指標値の測定方法
CN109799296A (zh) * 2019-01-28 2019-05-24 江南大学 一种用于细胞非靶向代谢组学分析的样品前处理方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
EP1904846A4 (en) 2005-06-29 2009-03-18 Rules Based Medicine Inc METHOD AND KITS FOR THE DIAGNOSIS OF ACUTE CORONARY SYNDROME
WO2007124439A2 (en) * 2006-04-21 2007-11-01 Rules-Based Medicine, Inc. Diagnosis of stroke using metalloproteinase or transaminase

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108027354A (zh) * 2015-08-20 2018-05-11 深圳华大生命科学研究院 冠心病的生物标志物
WO2017128161A1 (zh) * 2016-01-25 2017-08-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
WO2017128162A1 (zh) * 2016-01-25 2017-08-03 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN105866261A (zh) * 2016-03-24 2016-08-17 中国药科大学 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物群

Also Published As

Publication number Publication date
US20110045514A1 (en) 2011-02-24
WO2009049189A3 (en) 2009-06-18
JP2011501133A (ja) 2011-01-06
EP2210108A2 (en) 2010-07-28
AU2008310669A1 (en) 2009-04-16
IL204922A0 (en) 2010-11-30
EP2210108B1 (en) 2011-12-07
WO2009049189A2 (en) 2009-04-16
ATE536553T1 (de) 2011-12-15
ES2374762T3 (es) 2012-02-21
CA2702268A1 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
CN101939651A (zh) 用于检测严重有害的心血管和脑血管事件的方法
Bandhakavi et al. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva
Veenstra Global and targeted quantitative proteomics for biomarker discovery
JP2011501133A5 (enExample)
US8911960B2 (en) Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C
US20090155812A1 (en) Apolipoprotein fingerprinting technique and methods related thereto
US20030129760A1 (en) Mass intensity profiling system and uses thereof
JP2010510528A (ja) 自己免疫疾患のバイオマーカー
JP2006527190A (ja) ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法
JP2009540319A (ja) 質量分析バイオマーカーアッセイ
EP2293077A2 (en) Methods for detecting coronary artery disease
Novotny et al. Biochemical individuality reflected in chromatographic, electrophoretic and mass-spectrometric profiles
US20120178100A1 (en) Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
US8030011B2 (en) Biomarkers and assays for myocardial infarction
WO2014018643A1 (en) Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (tia) and peripheral arterial disease (pad)
EP3681528B1 (en) Identification and monitoring of apoptosis inhibitor of macrophage
US20060257946A1 (en) Serum biomarkers in ischaemic heart disease
Kienzl-Wagner et al. Biomarker discovery in transplantation—proteomic adventure or mission impossible?
JP2009210469A (ja) 血清たんぱく質の解析法
US10627414B2 (en) Attractin and lumican biomarkers in idiopathic pneumonia syndrome
LOPES‐VIRELLA et al. The immunogenicity of modified lipoproteins
HK1152751A (en) Methods for detecting major adverse cardiovascular and cerebrovascular events
Smith et al. Maximizing Analytical Performance in Biomolecular Discovery with LC-MS: Focus on Psychiatric Disorders
CN109870583B (zh) 急性胰腺炎相关的代谢物及其应用
Dankert et al. Mass Spectrometry Characterization of the Human Ankle and Hindfoot Fracture Microenvironment in Young and Aged Subjects

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1152751

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110105

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1152751

Country of ref document: HK